Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 3 6Phase 2 3

Status

Completed 3Unknown 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Pain 3Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasm Metastasis 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Completed × Analgesia × Clear all
NCT00029029 2020-08-12

Radiofrequency Ablation in Relieving Pain in Patients With Bones Metastases

Mayo Clinic

Phase 2 Completed

Neoplasm Metastasis, Pain

NCT00003781 2017-04-28

Docetaxel in Treating Patients With Stage IV Prostate Cancer

OHSU Knight Cancer Institute

Phase 2 Completed
25 enrolled
Genitourinary

Pain, Prostatic Neoplasms

NCT00040833 2013-06-05

Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Gastrointestinal

Pain, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡